Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

1.

Optimizing the delivery of interventions for harmful alcohol use in primary healthcare: an update.

Segura L, Anderson P, Gual A.

Curr Opin Psychiatry. 2018 Jul;31(4):324-332. doi: 10.1097/YCO.0000000000000435.

PMID:
29846264
2.

Reducing the health risks derived from exposure to addictive substances.

Anderson P, Gual A, Rehm J.

Curr Opin Psychiatry. 2018 Jul;31(4):333-341. doi: 10.1097/YCO.0000000000000432.

PMID:
29746421
3.

How does Economic Recession Affect Substance Use? A Reality Check with Clients of Drug Treatment Centres.

Bruguera P, Reynolds J, Gilvarry E, Braddick F, Marath-Veettil AL, Anderson P, Mielecka-Kubien Z, Kaner E, Gual A.

J Ment Health Policy Econ. 2018 Mar 1;21(1):11-16.

PMID:
29643264
4.

EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver.

J Hepatol. 2018 Jul;69(1):154-181. doi: 10.1016/j.jhep.2018.03.018. Epub 2018 Apr 5. No abstract available.

PMID:
29628280
5.

Reply to Braillon et al.: Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?

Barrio P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.

Clin Drug Investig. 2018 Apr;38(4):387-388. doi: 10.1007/s40261-018-0625-5. No abstract available.

PMID:
29480453
6.

Effectiveness of a Specialized Brief Intervention for At-risk Drinkers in an Emergency Department: Short-term Results of a Randomized Controlled Trial.

Bruguera P, Barrio P, Oliveras C, Braddick F, Gavotti C, Bruguera C, López-Pelayo H, Miquel L, Segura L, Colom J, Ortega L, Vieta E, Gual A.

Acad Emerg Med. 2018 May;25(5):517-525. doi: 10.1111/acem.13384. Epub 2018 Apr 2.

PMID:
29418049
7.

Alcohol, tobacco and health care costs: a population-wide cohort study (n = 606 947 patients) of current drinkers based on medical and administrative health records from Catalonia.

Miquel L, Rehm J, Shield KD, Vela E, Bustins M, Segura L, Colom J, Anderson P, Gual A.

Eur J Public Health. 2018 Jan 8. doi: 10.1093/eurpub/ckx236. [Epub ahead of print]

PMID:
29325000
8.

Filling the gap between lab and clinical impact: An open randomized diagnostic trial comparing urinary ethylglucuronide and ethanol in alcohol dependent outpatients.

Barrio P, Teixidor L, Ortega L, Lligoña A, Rico N, Bedini JL, Vieta E, Gual A.

Drug Alcohol Depend. 2018 Feb 1;183:225-230. doi: 10.1016/j.drugalcdep.2017.11.015. Epub 2017 Dec 27.

PMID:
29291550
9.

Scaling-up primary health care-based prevention and management of heavy drinking at the municipal level in middle-income countries in Latin America: Background and protocol for a three-country quasi-experimental study.

Anderson P, O'Donnell A, Kaner E, Gual A, Schulte B, Pérez Gómez A, de Vries H, Natera Rey G, Rehm J.

Version 3. F1000Res. 2017 Mar 23 [revised 2017 Jan 1];6:311. doi: 10.12688/f1000research.11173.3. eCollection 2017.

10.

Barriers to implement screening for alcohol consumption in Spanish hypertensive patients.

Miquel L, López-Pelayo H, Nuño L, Arbesú JÁ, Zarco J, Manthey J, Rehm J, Gual A.

Fam Pract. 2018 May 23;35(3):295-301. doi: 10.1093/fampra/cmx107.

PMID:
29106526
11.

Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results.

Barrio P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.

Clin Drug Investig. 2018 Feb;38(2):147-155. doi: 10.1007/s40261-017-0590-4.

PMID:
29080208
12.

Impact of practice, provider and patient characteristics on delivering screening and brief advice for heavy drinking in primary healthcare: Secondary analyses of data from the ODHIN five-country cluster randomized factorial trial.

Anderson P, Kłoda K, Kaner E, Reynolds J, Bendtsen P, Pelgrum-Keurhorst MN, Segura L, Wojnar M, Mierzecki A, Deluca P, Newbury-Birch D, Parkinson K, Okulicz-Kozaryn K, Drummond C, Laurant MGH, Gual A.

Eur J Gen Pract. 2017 Dec;23(1):241-245. doi: 10.1080/13814788.2017.1374365.

13.

Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union.

Rehm J, Anderson P, Prieto JAA, Armstrong I, Aubin HJ, Bachmann M, Bastus NB, Brotons C, Burton R, Cardoso M, Colom J, Duprez D, Gmel G, Gual A, Kraus L, Kreutz R, Liira H, Manthey J, Møller L, Okruhlica Ľ, Roerecke M, Scafato E, Schulte B, Segura-Garcia L, Shield KD, Sierra C, Vyshinskiy K, Wojnar M, Zarco J.

BMC Med. 2017 Sep 28;15(1):173. doi: 10.1186/s12916-017-0934-1.

14.

Delivery of Brief Interventions for Heavy Drinking in Primary Care: Outcomes of the ODHIN 5-Country Cluster Randomized Trial.

Anderson P, Coulton S, Kaner E, Bendtsen P, Kłoda K, Reynolds J, Segura L, Wojnar M, Mierzecki A, Deluca P, Newbury-Birch D, Parkinson K, Okulicz-Kozaryn K, Drummond C, Gual A.

Ann Fam Med. 2017 Jul;15(4):335-340. doi: 10.1370/afm.2051.

15.

Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long-term survival.

Altamirano J, López-Pelayo H, Michelena J, Jones PD, Ortega L, Ginès P, Caballería J, Gual A, Bataller R, Lligoña A.

Hepatology. 2017 Dec;66(6):1842-1853. doi: 10.1002/hep.29338.

PMID:
28646515
16.

Corrigendum: Barriers to Alcohol Screening Among Hypertensive Patients and the Role of Stigma: Lessons for the Implementation of Screening and Brief Interventions in European Primary Care Settings.

Hanschmidt F, Manthey J, Kraus L, Scafato E, Gual A, Grimm C, Rehm J.

Alcohol Alcohol. 2017 Sep 1;52(5):579. doi: 10.1093/alcalc/agx042. No abstract available.

PMID:
28633437
17.

Barriers to Alcohol Screening Among Hypertensive Patients and the Role of Stigma: Lessons for the Implementation of Screening and Brief Interventions in European Primary Care Settings.

Hanschmidt F, Manthey J, Kraus L, Scafato E, Gual A, Grimm C, Rehm J.

Alcohol Alcohol. 2017 Sep 1;52(5):572-579. doi: 10.1093/alcalc/agx032. Erratum in: Alcohol Alcohol. 2017 Sep 1;52(5):579.

PMID:
28541449
18.

The Standard Joint Unit.

Casajuana Kögel C, Balcells-Olivero MM, López-Pelayo H, Miquel L, Teixidó L, Colom J, Nutt DJ, Rehm J, Gual A.

Drug Alcohol Depend. 2017 Jul 1;176:109-116. doi: 10.1016/j.drugalcdep.2017.03.010. Epub 2017 May 16.

PMID:
28531767
19.

Risky Drinkers Underestimate their Own Alcohol Consumption.

Gual A, Ángel Arbesú J, Zarco J, Balcells-Oliveró MLM, López-Pelayo H, Miquel L, Bobes J.

Alcohol Alcohol. 2017 Jul 1;52(4):516-517. doi: 10.1093/alcalc/agx029. No abstract available.

PMID:
28498886
20.

Psychoactive constituents of cannabis and their clinical implications: a systematic review.

Casajuana Köguel C, López-Pelayo H, Balcells-Olivero MM, Colom J, Gual A.

Adicciones. 2018 Apr 15;30(2):140-151. doi: 10.20882/adicciones.858. English, Spanish.

Supplemental Content

Loading ...
Support Center